FDA Approval Clinical Implications: Dato-DXd for Unresectable or Metastatic HR+/HER2- BC - TROPION-Breast01 Trial | VuMedi

Find latest Breast Cancer videos · 1000+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

UCSF School of Medicine

FDA Approval Clinical Implications: Dato-DXd for Unresectable or Metastatic HR+/HER2- BC - TROPION-Breast01 Trial

By UCSF School of Medicine FEATURING Hope Rugo

By UCSF School of Medicine FEATURING Hope Rugo

334 views

March 4, 2025

Comments 0

Login to view comments. Click here to Login